A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma-Reference-Cited by-同舟云学术

A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma

Published:2016-10-31 Issue:1 Volume:8 Page:
ISSN:1756-994X
Container-title:Genome Medicine
language:en
Short-container-title:Genome Med

Author:

Dela Cruz Filemon S.,Diolaiti Daniel,Turk Andrew T.,Rainey Allison R.,Ambesi-Impiombato Alberto,Andrews Stuart J.,Mansukhani Mahesh M.,Nagy Peter L.,Alvarez Mariano J.,Califano Andrea,Forouhar Farhad,Modzelewski Beata,Mitchell Chelsey M.,Yamashiro Darrell J.,Marks Lianna J.,Glade Bender Julia L.,Kung Andrew L.

Funder

Jamie Deutsch Foundation

Ira Sohn Research Conference Foundation

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13073-016-0366-0.pdf

Reference84 articles.

1. Greco FA. Molecular diagnosis of the tissue of origin in cancer of unknown primary site: useful in patient management. Curr Treat Options Oncol. 2013;14(4):634–42.

2. Nystrom SJ, Hornberger JC, Varadhachary GR, Hornberger RJ, Gutierrez HR, Henner DW, et al. Clinical utility of gene-expression profiling for tumor-site origin in patients with metastatic or poorly differentiated cancer: impact on diagnosis, treatment, and survival. Oncotarget. 2012;3(6):620–8.